Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-36.71	17.74	28.03
Graham Fair Price	20.08	9800.16	8161.19
PEG	15.09	0.16	-0.14
Price/Book	-0.68	0.62	0.63
Price/Cash Flow	-68.71	21.18	67.69
Prices/Earnings	-30.65	7.13	10.28
Price/Sales	8.84	3.00	2.75
Price/FCF	-68.71	21.18	67.69
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	21.12	0.26	0.21
Operating Margin	25.60	0.10	0.08
ROA	40.07	0.02	0.01
ROE	0.02	0.02	43.21
ROIC	0.01	0.02	24.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.37	-0.27	-38.33
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.22	0.14	-34.84
EPS QOQ	-0.73	0.44	-39.75
FCF QOQ	-0.83	2.17	160.94
Revenue QOQ	0.04	-0.09	132.35
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	112.82	136.87	21.32
Days Sales Outstanding (DSO)	54.19	54.52	0.60
Inventory Turnover	0.80	0.66	-17.57
Debt/Capitalization	< 0.005	< 0.005	-37.01
Quick Ratio	4.24	3.41	-19.56
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13916.47	13964.19	0.34
Cash	3107.64	3490.43	12.32
Capex	-38.33	-11.39	70.29
Free Cash Flow	129.26	411.72	218.52
Revenue	3177.33	2909.23	-8.44
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	6.92	5.60	-19.07
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.04	-3.77	25.09
Naive Interpretation	Member

06 - Financial Health · Bad

Rating